Pulmonary arterial hypertension (PAH) is a progressive disease with limited survival. Iron deficiency (ID) correlates with disease severity and mortality. While oral iron supplementation was shown to be insufficient in such patients, the potential impact of parenteral iron on clinical measures warrants further investigation.

中文翻译：

---

肺动脉高压和缺铁患者的羧基麦芽糖铁：一项长期研究

肺动脉高压（PAH）是一种进行性疾病，生存期有限。缺铁 (ID) 与疾病严重程度和死亡率相关。虽然这些患者的口服铁补充剂被证明是不够的，但肠外铁对临床措施的潜在影响值得进一步研究。